CRLs (Cullin-RING E3 ubiquitin ligases) are the largest E3 ligase family in eukaryotes, which ubiquitinate a wide range of substrates involved in cell cycle regulation, signal transduction, transcriptional regulation, DNA damage response, genomic integrity, tumor suppression and embryonic development. CRL4 E3 ubiquitin ligase, as one member of CRLs family, consists of a RING finger domain protein, cullin4 (CUL4) scaffold protein and DDB1-CUL4 associated substrate receptors. The CUL4 subfamily includes two members, CUL4A and CUL4B, which share extensively sequence identity and functional redundancy. Aberrant expression of CUL4 has been found in a majority of tumors. Given the significance of CUL4 in cancer, understanding its detailed aspects of pathogenesis of human malignancy would have significant value for the treatment of cancer. Here, the work provides an overview to address the role of CRL4 E3 ubiquitin ligase in cancer development and progression, and discuss the possible mechanisms of CRL4 ligase involving in many cellular processes associated with tumor. Finally, we discuss its potential value in cancer therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767455 | PMC |
| http://dx.doi.org/10.18632/oncotarget.6052 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer.
Clin Transl Med
February 2025
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.
Background: The goal of precision oncology is to find effective therapeutics for every patient. Through the inclusion of emerging therapeutics in a high-throughput drug screening platform, our functional genomics pipeline inverts the common paradigm to identify patient populations that are likely to benefit from novel therapeutic strategies.
Approach: Utilizing drug screening data across a panel of 46 cancer cell lines from 11 tumor lineages, we identified an ovarian cancer-specific sensitivity to the first-in-class CRL4 inhibitors KH-4-43 and 33-11.
CUL4-Based Ubiquitin Ligases in Chromatin Regulation: An Evolutionary Perspective.
Cells
January 2025
Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.
Ubiquitylation is a post-translational modification that modulates protein function and stability. It is orchestrated by the concerted action of three types of enzymes, with substrate specificity governed by ubiquitin ligases (E3s), which may exist as single proteins or as part of multi-protein complexes. Although Cullin (CUL) proteins lack intrinsic enzymatic activity, they participate in the formation of active ubiquitin ligase complexes, known as Cullin-Ring ubiquitin Ligases (CRLs), through their association with ROC1 or ROC2, along with substrate adaptor and receptor proteins.
View Article and Find Full Text PDFRab40 GTPases regulate AMBRA1-mediated transcription and cell migration.
bioRxiv
November 2024
Department of Cell and Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Article Synopsis
- The Rab40 subfamily consists of small GTPases that form a complex with CRL5, an E3 ligase, and are involved in the ubiquitylation of specific proteins, influencing cell migration.
- Recent research has identified AMBRA1 as a new partner of Rab40, linking the functions of CRL4 and CRL5 E3 ligases, impacting gene transcription without leading to AMBRA1's degradation.
- The study highlights that Rab40's ubiquitylation of AMBRA1 is crucial for regulating genes associated with cell adhesion and migration, indicating a significant role for the Rab40/CRL5 complex in these processes.
Deciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation.
Sci Rep
November 2024
Department of Biosciences, Jamia Millia Islamia, New Delhi, India.
Article Synopsis
- Breast cancer is caused by abnormal breast cells that can form tumors, which can spread and become deadly if not treated.
- The study aimed to understand the molecular changes from Ductal Carcinoma In Situ (DCIS) to Invasive Ductal Carcinoma (IDC) by identifying important hub genes related to this transition and potential treatments.
- Ten key hub genes linked to tumor progression were identified, with CDK1 and DTL being significant, and the study found that the anti-inflammatory compound Fisetin effectively binds to these genes, suggesting it could help in targeting treatment for breast cancer.
Arginine methylation-dependent TRIM47 stability mediated by CARM1 promotes the metastasis of hepatocellular carcinoma.
Cell Death Discov
November 2024
Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Wuhan, China.
The tripartite motif (TRIM) protein family has been shown to play important roles in the occurrence and development of various tumors. However, the biological functions of TRIM47 and its regulatory mechanism in hepatocellular carcinoma (HCC) remain unexplored. Here, we showed that TRIM47 was upregulated in HCC tissues compared with adjacent normal tissues, especially at advanced stages, and associated with poor prognosis in HCC patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!